I agree that this site is using cookies. You can find further informations here.
X
Keeping, S
95  results:
Search for persons X
?
1

SA1 Methods for Incorporating Non-Randomized Evidence From ..:

Mojebi, A ; Zheng, D ; Park, J...
Value in Health.  27 (2024)  6 - p. S396 , 2024
Link: https://doi.org/10.1016/..
 
?
2

CO137 Are Standard Indirect Treatment Comparison Methods Su..:

Dillon, R. ; Wilson, F. ; Chan, K....
Value in Health.  27 (2024)  6 - p. S42 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Comparative Efficacy of KEYNOTE-B10 Regimen as First-Line (..:

Zheng, D. ; Black, C.M. ; Mojebi, A...
International Journal of Radiation Oncology*Biology*Physics.  118 (2024)  5 - p. e32-e33 , 2024
Link: https://doi.org/10.1016/..
 
?
4

EE505 Predictive Analysis Comparing Economic and Clinical C..:

Keeping, S ; Zhang, W ; Berardi, A...
Value in Health.  27 (2024)  6 - p. S150 , 2024
Link: https://doi.org/10.1016/..
 
?
5

MT10 Clinical and Economic Impact of Point-of-Care (POC) Mo..:

Hale, B. ; Mojebi, A. ; Wu, P...
Value in Health.  26 (2023)  12 - p. S428 , 2023
Link: https://doi.org/10.1016/..
 
?
6

Matching‐adjusted indirect comparison (MAIC) of zanubrutini..:

Thieblemont, C. ; Wang, K. ; Keeping, S....
Hematological Oncology.  41 (2023)  S2 - p. 388-389 , 2023
Link: https://doi.org/10.1002/..
 
?
7

81P Real-world experience with docetaxel regimens in metast..:

Bittoni, M.A. ; Keeping, S. ; Carbone, D.P....
Immuno-Oncology and Technology.  20 (2023)  - p. 100553 , 2023
Link: https://doi.org/10.1016/..
 
?
8

EE280 Budget Impact (BI) of First-Line (1L) Cemiplimab Mono..:

Quek, RGW ; Theriou, C ; Smare, C...
Value in Health.  25 (2022)  7 - p. S388 , 2022
Link: https://doi.org/10.1016/..
 
?
9

SA29 Efficacy Outcomes Following Treatment with Bruton Tyro..:

Dreyling, M ; Shah, B ; Wu, JJ...
Value in Health.  25 (2022)  7 - p. S609-S610 , 2022
Link: https://doi.org/10.1016/..
 
?
10

PCN12 A Systematic Literature Review (SLR) of Clinical Outc..:

Yang, X. ; Murphy, P. ; Thosar, M...
Value in Health.  24 (2021)  - p. S20-S21 , 2021
Link: https://doi.org/10.1016/..
 
?
11

1. Indirect Treatment Comparison of Pembrolizumab Versus St..:

Wu, E ; Keeping, S ; Chan, K..
Value in Health.  21 (2018)  - p. S223 , 2018
Link: https://doi.org/10.1016/..
 
?
12

PCN21 - COMPARATIVE EFFICACY OF NIVOLUMAB±IPILIMUMAB VERSUS..:

Cope, S. ; Popoff, E. ; Keeping, S....
Value in Health.  21 (2018)  - p. S18 , 2018
Link: https://doi.org/10.1016/..
 
?
13

Observed Versus Estimated Acquisition Costs Associated with..:

Keeping, S ; Deslandes, PN ; Haines, K.
Value in Health.  20 (2017)  9 - p. A407 , 2017
Link: https://doi.org/10.1016/..
 
?
14

Re-thinking risk communication: information needs of patien..:

Dickmann, P. ; Wittgens, K. ; Keeping, S...
Public Health.  131 (2016)  - p. 56-62 , 2016
Link: https://doi.org/10.1016/..
 
?
15

Bluetooth Low Energy: Wireless Connectivity for Medical Mon..:

Omre, A. H. ; Keeping, S.
Journal of Diabetes Science and Technology.  4 (2010)  2 - p. 457-463 , 2010
Link: https://doi.org/10.1177/..
 
1-15